AMEC to expand pharma plant design biz with $3bn Foster Wheeler buy
AMEC has announced its plan to buy US firm Foster Wheeler AG for $3.2bn (€2.3bn) in a deal that includes the latter’s pharmaceutical plant design services business.
Archives for January 13, 2014
The economic pain in Spain not slowing CMO gains says IDIFarma
Current economic problems may have hit Spanish drugmakers hard, but the downturn has not dampened demand for contract manufacturing services according to IDIFarma.
Aurobindo extinguishes fire reports; Amgen confirms explosion
Aurobindo has denied reports of a boiler blast at an Andhra Pradesh, India facility whilst Amgen is investigating an incident at its San Francisco R&D site.
Horizon Discovery bags second AstraZeneca contract
All the obvious cancer targets have been found according to Horizon Discovery, which last week agreed to help AstraZeneca find some new ones using isogenic pairs of oncology relevant cells.
Ranbaxy receives US FDA Form 483 at Indian API plant
An Indian API facility has received a form 483 from the US FDA in the latest setback for troubled drugmaker Ranbaxy.
Alnylam buys Merck's siRNA tech biz as Sanofi inks $700m alliance
Alnylam has both acquired Merck & Co. subsidiary Sirna therapeutics and extended an alliance with Genzyme in order to advance its small interfering RNA (siRNA) delivery programme.